Stock Scorecard
Stock Summary for Privia Health Group Inc (PRVA) - $20.79 as of 11/20/2024 8:36:49 PM EST
Total Score
12 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PRVA
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PRVA
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PRVA
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PRVA
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for PRVA (28 out of 90)
Stock Price Rating (Max of 10) | 7 |
Historical Stock Price Rating (Max of 10) | 1 |
Stock Price Trend (Max of 10) | 0 |
Book Value (Max of 10) | 4 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 5 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 5 |
Price to Earnings (Max of 10) | 1 |
Latest News for for PRVA
Financial Details for PRVA
Company Overview |
|
---|---|
Ticker | PRVA |
Company Name | Privia Health Group Inc |
Country | USA |
Description | Privia Health Group, Inc. is a population health technology and medical practice management company in the United States. |
Sector Name | LIFE SCIENCES |
Industry Name | SERVICES-HEALTH SERVICES |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 20.79 |
Price 4 Years Ago | 0.00 |
Last Day Price Updated | 11/20/2024 8:36:49 PM EST |
Last Day Volume | 449,129 |
Average Daily Volume | 862,631 |
52-Week High | 24.30 |
52-Week Low | 15.92 |
Last Price to 52 Week Low | 30.59% |
Valuation Measures |
|
Trailing PE | 190.45 |
Industry PE | 113.04 |
Sector PE | 40.32 |
5-Year Average PE | 101.75 |
Free Cash Flow Ratio | 5.91 |
Industry Free Cash Flow Ratio | 86.85 |
Sector Free Cash Flow Ratio | 27.97 |
Current Ratio Most Recent Quarter | 1.78 |
Total Cash Per Share | 3.52 |
Book Value Per Share Most Recent Quarter | 5.13 |
Price to Book Ratio | 4.14 |
Industry Price to Book Ratio | 4.44 |
Sector Price to Book Ratio | 20.88 |
Price to Sales Ratio Twelve Trailing Months | 1.48 |
Industry Price to Sales Ratio Twelve Trailing Months | 1.76 |
Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
Analyst Buy Ratings | 14 |
Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
Total Shares Outstanding | 120,001,000 |
Market Capitalization | 2,494,820,790 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -38.40% |
Annual Earnings Growth | 368.83% |
Reported EPS 12 Trailing Months | 0.11 |
Reported EPS Past Year | 0.08 |
Reported EPS Prior Year | 0.19 |
Net Income Twelve Trailing Months | 12,824,000 |
Net Income Past Year | 23,079,000 |
Net Income Prior Year | -8,585,000 |
Quarterly Revenue Growth YOY | 4.90% |
5-Year Revenue Growth | 31.39% |
Operating Margin Twelve Trailing Months | 0.01 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 421,997,000 |
Total Cash Past Year | 389,511,000 |
Total Cash Prior Year | 347,992,000 |
Net Cash Position Most Recent Quarter | 324,209,000 |
Net Cash Position Past Year | 290,448,000 |
Long Term Debt Past Year | 99,063,000 |
Long Term Debt Prior Year | 99,063,000 |
Total Debt Most Recent Quarter | 97,788,000 |
Equity to Debt Ratio Past Year | 0.85 |
Equity to Debt Ratio Most Recent Quarter | 0.86 |
Total Stockholder Equity Past Year | 561,437,000 |
Total Stockholder Equity Prior Year | 499,094,000 |
Total Stockholder Equity Most Recent Quarter | 614,886,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 88,550,000 |
Free Cash Flow Per Share Twelve Trailing Months | 0.74 |
Free Cash Flow Past Year | 80,672,000 |
Free Cash Flow Prior Year | 47,092,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 1.13 |
MACD Signal | 0.70 |
20-Day Bollinger Lower Band | 16.46 |
20-Day Bollinger Middle Band | 19.08 |
20-Day Bollinger Upper Band | 21.70 |
Beta | 0.76 |
RSI | 65.03 |
50-Day SMA | 19.50 |
150-Day SMA | 24.40 |
200-Day SMA | 0.00 |
System |
|
Modified | 11/19/2024 10:42:40 AM EST |